Complejo Hospitalario Universitario de Lugo
Centro asistencial
University of Manchester
Mánchester, Reino UnidoPublicaciones en colaboración con investigadores/as de University of Manchester (34)
2023
-
Cluster Analyses From the Real-World NOVELTY Study: Six Clusters Across the Asthma-COPD Spectrum
Journal of Allergy and Clinical Immunology: In Practice, Vol. 11, Núm. 9, pp. 2803-2811
2020
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab and omalizumab) for severe allergic asthma: A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1043-1057
-
Efficacy and safety of treatment with biologicals (benralizumab, dupilumab, mepolizumab, omalizumab and reslizumab) for severe eosinophilic asthma. A systematic review for the EAACI Guidelines - recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1023-1042
-
Efficacy and safety of treatment with dupilumab for severe asthma: A systematic review of the EAACI guidelines—Recommendations on the use of biologicals in severe asthma
Allergy: European Journal of Allergy and Clinical Immunology, Vol. 75, Núm. 5, pp. 1058-1068
-
International severe asthma registry (ISAR): Protocol for a global registry
BMC Medical Research Methodology, Vol. 20, Núm. 1
2019
-
Development of the International Severe Asthma Registry (ISAR): A Modified Delphi Study
Journal of Allergy and Clinical Immunology: In Practice, Vol. 7, Núm. 2, pp. 578-588.e2
2015
-
A large-scale genetic analysis reveals a strong contribution of the HLA class II region to giant cell arteritis susceptibility
American Journal of Human Genetics, Vol. 96, Núm. 4, pp. 565-580
2011
-
Interleukin-1 beta gene polymorphism in patients with biopsy-proven erythema nodosum
Clinical and Experimental Rheumatology
2010
-
Interleukin-1 receptor antagonist gene polymorphism in patients with biopsy-proven erythema nodosum
Clinical and Experimental Rheumatology
2009
2008
-
Contribution of HLA-DRB1 shared epitope alleles and chronic inflammation to the increased incidence of cardiovascular disease in rheumatoid arthritis: Comment on the article by Farragher et al.
Arthritis and Rheumatism
-
Interleukin-6 promoter polymorphism at position - 174 in biopsy-proven patients with erythema nodosum from a defined population
Clinical and Experimental Rheumatology
2007
-
HLA-DRB1 and persistent chronic inflammation contribute to cardiovascular events and cardiovascular mortality in patients with rheumatoid arthritis
Arthritis Care and Research, Vol. 57, Núm. 1, pp. 125-132
-
Lack of association between interleukin-6 promoter polymorphism at position -174 and Henoch-Schönlein purpura
Clinical and Experimental Rheumatology, Vol. 25, Núm. 1 SUPPL. 44
-
Persistent Chronic Inflammation Contributes to the Development of Cancer in Patients with Rheumatoid Arthritis from a Defined Population of Northwestern Spain
Seminars in Arthritis and Rheumatism, Vol. 37, Núm. 1, pp. 31-38
2006
-
Lack of association between macrophage migration inhibitory factor gene (-173 G/C) polymorphism and cutaneous vasculitis
Clinical and Experimental Rheumatology, Vol. 24, Núm. 5, pp. 576-579
2005
-
Inducible nitric oxide synthase polymorphism is associated with susceptibility to Henoch-Schönlein purpura in Northwestern Spain
Journal of Rheumatology, Vol. 32, Núm. 6, pp. 1081-1085
-
Lack of association between macrophage migration inhibitory factor gene polymorphism and giant cell arteritis
Journal of Rheumatology, Vol. 32, Núm. 1, pp. 74-76
2004
-
E-selectin polymorphism in erythema nodosum secondary to sarcoidosis
Clinical and Experimental Rheumatology, Vol. 22, Núm. 2, pp. 230-232
-
Echocardiographic and Doppler Findings in Long-Term Treated Rheumatoid Arthritis Patients without Clinically Evident Cardiovascular Disease
Seminars in Arthritis and Rheumatism, Vol. 33, Núm. 4, pp. 231-238